Amylyx Pharmaceuticals Announces Pricing Of Upsized $500 Million Underwritten Public Offering Of Common Stock

Aug. 19 (Reuters) - Amylyx Pharmaceuticals, Inc. (AMLX.O):

• Amylyx Pharmaceuticals announces pricing of an upsized $500 million underwritten public offering of common stock.
• Amylyx Pharmaceuticals announces an upsized public offering of 14,090,000 shares at $35.50 per share.

Source text: ID:nBw2h1CcNa